Subject to change.
Subject to change.
Dr. Junya Fukuoka is a professor and department chair of pathology Informatics at Nagasaki University, renowned for his expertise in pulmonary pathology and digital pathology. He has been incorporating digital devices into his lectures and practice for many years, earning high praise from both medical students and clinicians for his engaging and accessible teaching style. With over 270 publications and over 12,000 citations, Dr. Fukuoka is a prolific contributor to his field.
Asia is a region of immense diversity, with distinct cultural, economic, and linguistic differences that present unique challenges and vast potential. Recently, countries like China, India, South Korea, Singapore, Australia, Dubai, and Japan have emerged as global leaders in science, yet Asia lags behind Europe and the U.S. in digital pathology and AI. To address this, the Asian Society of Digital Pathology (ASDP) was founded in Singapore in February 2024. ASDP aims to standardize practices, establish reference centers, and promote research and education across Asia. This session will introduce ASDP's vision and present findings from our large-scale survey on digital pathology in Asia, highlighting current trends and future potential. We will also host a panel discussion with ASDP leaders on strategies to maximize Asia's potential and explore collaborations with global organizations.
Since its inception in 2009, the Digital Pathology Association (DPA) has been at the forefront of driving innovation in digital pathology (DP) and augmented intelligence (AI) within healthcare and life sciences. Recognizing the power of collaboration, DPA has forged strong partnerships with like-minded professional societies and organizations. Join us for this exclusive panel discussion featuring the Presidents of four distinguished allied societies. Together, they will provide a high-level overview of the current landscape of DP and AI, highlighting both the advancements and challenges facing the field. Panelists will delve into the strategies and initiatives implemented by their respective societies to propel DP and AI forward. They will also explore opportunities to strengthen collaborations and address critical issues such as education, regulation, and reimbursement. This interactive session is designed to foster open dialogue and encourage audience participation in this vital conversation about the future of pathology.
Learning Objectives: